Roche revenue drops as key products underperform
October 13, 2011Sales and Marketing Roche
Roche has posted worse-than-expected figures for the first nine months of this year after key products failed to shine and …
NICE recommends RoActemra for early use in arthritis
October 13, 2011Sales and Marketing NICE, RoActemra
NICE has recommended Roche’s drug RoActemra be used at an earlier stage for some arthritis patients. In draft guidance NICE …
Lords’ Health Bill challenge fails
October 12, 2011NHS reform
The government’s NHS reforms have survived a challenge in the House of Lords that have delayed them until the next …
Bayer planning joint venture to make drugs in Russia
October 12, 2011Manufacturing and Production Bayer, pharma manufacturing news
Germany’s Bayer AG has joined a number of its peers in the pharmaceutical industry with the signing of an agreement …
Pharmacovigilance at heart of EC patient information proposals
October 12, 2011Medical Communications, Sales and Marketing patient information
Pharmacovigilance is at the centre of revised proposals announced this week setting out what information pharma firms can put on …
Charities support new electronic patient records
October 12, 2011Sales and Marketing IT, NHS, electronic patient records
The troubled project to launch an NHS-wide electronic patient record system has received new support from patient groups.The Summary Care …
Quintiles opens new European headquarters in the UK
October 12, 2011Research and Development Quintiles, research and development news
Pharmaceutical services company Quintiles has opened a new European headquarters in the UK. The Reading, Berkshire facility will house more …
Peers to vote on delaying the Health Bill
October 12, 2011NHS reforms
The government’s health reforms face the prospect of a significant delay if a vote today goes against them. Peers in …
MS audit finds little improvement in care
October 12, 2011MS, multiple sclerosis
There has been “little or no improvement” in the care of multiple sclerosis patients over the past five years, according …
Pharma manufacturing news in brief
October 12, 2011Manufacturing and Production pharma manufacturing news
FDA sets aside $35m for manufacturing research, Anteco, Apicore and Vetter provide facility updates and Domino Printing sets up a …
Stallergenes Moves to the Cloud with Veeva CRM
October 11, 2011BARCELONA, SPAIN — 11 October, 2011 – Stallergenes, the world leader in sublingual immunotherapy, has selected Veeva CRM to replace …
India will scrutinise foreign investment in pharma
October 11, 2011Manufacturing and Production, Research and Development, Sales and Marketing India, Indian pharmaceutical industry
The Indian government has decided not to put any restrictions on the level of foreign direct investment (FDI) in the …
Parexel to work with Singapore on clinical research training
October 11, 2011Research and Development Asia, CRO, Parexel, Singapore, clinical research
Parexel and the National University of Singapore have launched a new academic course to train Asia’s scientist to work in …
‘Paralysis’ in NHS if reforms passed
October 11, 2011Andrew Lansley, Health and Social Care Bill, Mike Farrar, NHS
A prominent NHS leader has warned the government’s reforms are unworkable in their current form. NHS Confederation chief executive Mike …
AstraZeneca plans $200m manufacturing plant in China
October 11, 2011Manufacturing and Production AstraZeneca, China, pharma manufacturing news
AstraZeneca has announced plans to set up a manufacturing facility in north-eastern China, backed by a record investment by the …
Pfizer taps into Saudi stimulus package with new plant
October 10, 2011Manufacturing and Production Pfizer, pharma manufacturing news
Pfizer has unveiled expansion plans for the Middle East region with an agreement to open a manufacturing plant in Saudi …
Novo Nordisk’s Victoza launched in China
October 10, 2011Sales and Marketing Byetta, China, Victoza, diabetes
Novo Nordisk’s Victoza is now available in China, one of the fastest growing diabetes markets in the world. Victoza (liraglutide …
US approval for Merck’s Januvia-Zocor combination
October 10, 2011Sales and Marketing Januvia, Juvisync, Zocor
US regulators have given the green light to the latest in Merck & Co’s stable of brands aimed at type …
Janssen launches Incivo in the UK
October 10, 2011Sales and Marketing Incivek, Incivo
Janssen’s new hepatitis C treatment Incivo has been launched in the UK, one of two new drugs set to advance …
Merck & Co chairman Richard Clark retires
October 10, 2011Research and Development, Sales and Marketing appointment, sales and marketing
Richard Clark will step down as chairman of Merck & Co on 1 December after leading the company for six …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
